Slide 1

Recommendations for IMRT use

1) If the

reduction of xerostomia

and improved quality of

life are the main outcomes of interest, then

IMRT

is the

recommended

treatment

2) If

blindness

is to be minimized or avoided,

IMRT

indicated

in the definitive or adjuvant radiotherapy setting for nasal and

paranasal sinus cancers

3) If

osteoradionecrosis

is to be minimized or avoided,

IMRT

indicated

in the definitive or adjuvant radio- therapy of

tumours in the oral cavity, oropharynx, paranasal sinuses and

nasopharynx

4) If

treatment-related outcomes

(local control, overall

survival) are the main outcomes of interest, there are

no randomized

data to support or refute a recommendation of IMRT

over two-

or three-dimensional EBRT in any head and neck site

O’Sullivan, B., Rumble, R. B., & Warde, P. (2012). Intensity-modulated Radiotherapy in

the Treatment of Head and Neck Cancer. Clinical Oncology, 24(7), 474–487